Intuitive Surgical (NASDAQ:ISRG) Stock Price Up 1.2% Following Analyst Upgrade

Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report)’s stock price shot up 1.2% on Thursday after BTIG Research raised their price target on the stock from $469.00 to $494.00. BTIG Research currently has a buy rating on the stock. Intuitive Surgical traded as high as $487.94 and last traded at $487.79. 166,789 shares traded hands [...]

featured-image

Intuitive Surgical, Inc. ( NASDAQ:ISRG – Get Free Report )’s stock price shot up 1.2% on Thursday after BTIG Research raised their price target on the stock from $469.

00 to $494.00. BTIG Research currently has a buy rating on the stock.



Intuitive Surgical traded as high as $487.94 and last traded at $487.79.

166,789 shares traded hands during mid-day trading, a decline of 89% from the average session volume of 1,519,489 shares. The stock had previously closed at $482.21.

A number of other equities research analysts also recently commented on the company. Barclays raised their target price on Intuitive Surgical from $430.00 to $490.

00 and gave the company an “overweight” rating in a report on Thursday, July 18th. The Goldman Sachs Group assumed coverage on Intuitive Surgical in a report on Thursday, May 30th. They issued a “buy” rating and a $500.

00 target price for the company. Morgan Stanley lifted their price target on Intuitive Surgical from $375.00 to $460.

00 and gave the stock an “equal weight” rating in a research note on Monday, July 15th. Truist Financial lifted their price target on Intuitive Surgical from $450.00 to $515.

00 and gave the stock a “buy” rating in a research note on Tuesday, July 16th. Finally, Citigroup lifted their price target on Intuitive Surgical from $512.00 to $560.

00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Six analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.

com, the stock has a consensus rating of “Moderate Buy” and an average price target of $446.45. Read Our Latest Research Report on Intuitive Surgical Insider Buying and Selling at Intuitive Surgical Institutional Trading of Intuitive Surgical Institutional investors have recently modified their holdings of the company.

Advisors Asset Management Inc. boosted its holdings in Intuitive Surgical by 18.1% in the 1st quarter.

Advisors Asset Management Inc. now owns 7,380 shares of the medical equipment provider’s stock worth $2,945,000 after acquiring an additional 1,129 shares during the period. Provence Wealth Management Group acquired a new position in Intuitive Surgical in the 4th quarter worth $276,000.

Public Employees Retirement System of Ohio lifted its holdings in Intuitive Surgical by 5.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 191,283 shares of the medical equipment provider’s stock worth $64,531,000 after buying an additional 9,869 shares in the last quarter.

HCR Wealth Advisors boosted its position in Intuitive Surgical by 26.3% in the 4th quarter. HCR Wealth Advisors now owns 1,042 shares of the medical equipment provider’s stock valued at $352,000 after buying an additional 217 shares during the last quarter.

Finally, Checchi Capital Advisers LLC grew its stake in shares of Intuitive Surgical by 2.5% during the fourth quarter. Checchi Capital Advisers LLC now owns 2,875 shares of the medical equipment provider’s stock valued at $970,000 after acquiring an additional 70 shares in the last quarter.

Hedge funds and other institutional investors own 83.64% of the company’s stock. Intuitive Surgical Price Performance The firm has a market capitalization of $172.

80 billion, a PE ratio of 87.94, a price-to-earnings-growth ratio of 4.97 and a beta of 1.

39. The stock has a 50-day moving average price of $452.39 and a 200-day moving average price of $413.

17. Intuitive Surgical ( NASDAQ:ISRG – Get Free Report ) last posted its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.

78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24.

Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%.

The company had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion.

During the same period in the previous year, the business earned $1.18 EPS. Intuitive Surgical’s revenue for the quarter was up 14.

5% compared to the same quarter last year. As a group, equities research analysts predict that Intuitive Surgical, Inc. will post 5.

22 earnings per share for the current fiscal year. Intuitive Surgical Company Profile ( Get Free Report ) Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter ..